✦ LIBER ✦
T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic Approaches
✍ Scribed by Koehne, Guenther; Devlin, Sean; Landau, Heather; Hassoun, Hani; Lesokhin, Alexander M.; Lendvai, Nikoletta; Chung, David J.; Bravo, Christina; Giralt, Sergio A.
- Book ID
- 122165720
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 54 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1083-8791
No coin nor oath required. For personal study only.